Sevoflurane is a fluorinated methyl isopropyl ether. It has a number of properties that make it potentially suitable as a volatile anaesthetic agent for paediatric practice. These include a low blood solubility with the potential for more rapid onset and offset of anaesthesia, non-pungency and low airway irritability allowing inhalational induction, low arrhythmogenicity and limited cardiovascular depression 1, 2 .
The aims of this study were to compare induction, emergence and cardiovascular parameters in day case paediatric surgical patients receiving sevoflurane or halothane. Similar studies have been performed in other countries 2, 3, 4 , but this was the first comparison in an Australian population.
PATIENTS AND METHODS
Following Ethics Committee approval, this phase III, open label, randomized comparative study was conducted at the Royal Children's Hospital, Melbourne. Written informed consent was obtained from the parents of 52 ASA 1 and 2 children aged from two to thirteen years. One patient was excluded due to technical problems with the initial vaporizer and one patient had his operation cancelled for surgical reasons prior to reaching the operating theatre. Fifty patients were randomly assigned to receive either sevoflurane or halothane using a computer-generated randomization schedule. The drug allocation was contained in a sealed envelope which was opened following parental consent and recruitment into the study. Twenty-four patients received sevoflurane and twenty-six received halothane. Patients undergoing elective lower abdominal and genitourinary surgery were chosen, as these procedures are routinely performed using spontaneous ventilation general anaesthesia with local anaesthetic blocks and paracetamol for postoperative analgesia. Exclusion criteria included ASA status 3, 4 or 5; a history of significant cardiac, respiratory, neurological, renal, hepatic or musculoskeletal abnormalities; patients receiving drugs potentially affecting renal or hepatic function; history of recent general (coughing, breath-holding, bronchospasm, laryngospasm) were more common during induction with halothane, and excitement more common in children receiving sevoflurane. Emergence times were significantly more rapid in children who had received sevoflurane (21.4±10.9 versus 33.1 ±13.7 minutes; P<0.01). Objective pain/discomfort scores were higher in patients receiving sevoflurane at 10, 20, 30 and 40 minutes after arrival in the recovery room, and the incidence of excitement during emergence was higher in this group. It is concluded that sevoflurane is well tolerated for inhalational induction and has an improved cardiovascular profile compared to halothane. Emergence was significantly more rapid following sevoflurane.
anaesthesia; or expected duration of anaesthesia greater than three hours. In the Day Surgery Unit, urine samples were obtained for urinalysis and baseline recordings of blood pressure, heart rate, and body weight were taken. A trained nurse observer remained with the patient until discharge, and continued to record perioperative data on standardized written records.
All children received oral midazolam 0.5 mg/kg to a maximum dose of 15 mg thirty minutes prior to induction of anaesthesia. Paracetamol was given orally (20 mg/kg) with the premedication, or rectally (25 to 30 mg/kg) following induction of anaesthesia. The induction of anaesthesia was performed in an anaesthetic room, and in accordance with our current hospital practice, a parent of the child was present during the induction if they wished. Electrocardiograph (ECG), non-invasive blood pressure, and pulse oximetry monitoring was commenced prior to induction of anaesthesia, and airway gas was analysed for oxygen, nitrous oxide, carbon dioxide and anaesthetic agent with digital and capnograph displays by a Datex Capnomac Ultima. The monitor was calibrated prior to the study, the same monitor was used for all patients and a digital readout of data was retained. A nasopharyngeal temperature probe was inserted following induction of anaesthesia. Breathing circuits used were the Ayres T-piece with Jackson Rees modification with a fresh gas flow rate appropriate to the weight of the child, or a circle system with soda lime absorbent and a minimum fresh gas flow of three litres per minute. The Fluotec 3 vaporizer was used to deliver halothane and the Penlon Sigma Elite to deliver sevoflurane.
A standardized, graded inhalational induction technique was used. Following application of a facemask, 66% nitrous oxide in oxygen was administered for 30 seconds. Volatile agent was then introduced in increments of 0.5% halothane and 1% sevoflurane every five breaths to a maximum of 7% sevoflurane and 3.5% halothane. The time to loss of eyelash reflex and end of induction (defined as the pupils returning to a constricted and central position) were recorded. Induction events (coughing, breathholding, excitement, laryngospasm, bronchospasm, increased secretions, vomiting, shivering) were noted and graded by the investigator as mild, moderate or severe. An intravenous cannula was inserted, blood withdrawn for sampling, and the cannula capped (intravenous fluids were not administered). A laryngeal mask airway was then inserted. Local anaesthetic nerve block appropriate for the surgical procedure was performed with bupivacaine (maximum dose 2.5 mg/kg). Monitoring was continued as the patient was transferred to the operating room. Cardiovascular and airway gas data were recorded every minute from induction to incision for up to 15 minutes, and then five-minutely until completion of the anaesthetic.
During the maintenance phase, the aim was to provide a relatively constant inspired anaesthetic concentration (approximating 0.8 to 1% halothane or 1.5 to 2% sevoflurane). No tapering of anaesthetic agent was allowed during the procedure, in an attempt to standardize emergence times. On completion of surgery, volatile anaesthetic agent and nitrous oxide were ceased, 100% oxygen was administered, the laryngeal mask airway removed, and the patient transferred to the recovery room.
In addition to standard recovery room monitoring, the trained nurse observer recorded blood pressure, heart rate and pulse oximetry data on arrival in the recovery room and at five-minute intervals. Several time points were recorded from arrival in the recovery room. Emergence time was defined as the time when the patient opened his/her eyes or responded to verbal command; command response time as the time the patient squeezed the observer's or parent's hand on command or demonstrated purposeful movement; and time to orientation to name and age were recorded in older patients. A modified Aldrete recovery score and objective pain discomfort score were recorded at ten-minute intervals (see Appendix 1 and 2). Emergence events were noted and graded in severity by the nurse observer.
Blood for laboratory testing was withdrawn from the intravenous cannula (which had remained in situ postoperatively) two hours following completion of surgery, and a urine sample obtained for urinalysis. Laboratory tests included haemoglobin, haematocrit, white cell count and differential, platelet count, serum electrolytes (sodium, potassium, chloride, bicarbonate, calcium), urea, creatinine, uric acid, glucose, and liver function tests (albumin, total protein, total bilirubin, aspartate aminotransferase, alkaline phosphatase, lactate dehydrogenase, alanine transferase). Urinalysis was performed testing for pH, presence of protein, glucose, blood and leucocytes. All patients were reviewed by one of the investigators prior to discharge. Discharge criteria included stable vital signs for at least one hour, analgesia controlled with current local anaesthetic blocks and/or oral analgesia, minimal nausea or vomiting, and ability to tolerate oral fluids. A followup telephone questionnaire was completed 24 hours after discharge. Occurrence of fever, nausea, vomiting, coughing, dizziness and drowsiness were recorded. In addition, patients were asked if they remembered anything specific during the operation, and parents if they would like their child to have the same anaesthetic administered again.
Nominal data including the incidences of adverse events during induction and emergence were analysed using Fisher's exact test. Student's t test was used for induction and emergence times and haemodynamic data (GraphPad Instat V2.04). Data are presented as mean and standard deviation. Statistical significance was accepted for P< 0.05.
RESULTS
Data from 50 patients were analysed; 26 patients received halothane and 24 patients received sevoflurane. Demographic data and the duration of surgery and anaesthesia were similar for the two treatment groups (Table 1 ). Due to the type of surgery chosen ( Table 2 ) there was a predominance of males in the study, but there was no difference in gender distribution between the two groups. Local anaesthetic blocks were performed in 45 patients and included caudal epidural, ilioinguinal nerve blocks and infiltration in the surgical area. Two patients in the halothane group and one in the sevoflurane group received both ilioinguinal and caudal local anaesthetic to cover the inguinal and scrotal incisions of orchidopexy. Five patients undergoing cystoscopy had no local anaesthetic administered and received paracetamol as the sole analgesic ( Table 3) .
The time to loss of eyelash reflex and the time to end of induction tended to be shorter in patients receiving sevoflurane, but the difference did not achieve statistical significance ( Table 4 ). The occurrence of adverse events during induction revealed a higher incidence of respiratory events (coughing, laryngospasm, breath-holding) in patients receiving halothane and a higher incidence of excitement in patients receiving sevoflurane (Table 5 ), but the differences were not statistically significant. The overall induction success, defined as absence of any of the adverse induction events, was similar for both agents ( Table 6 ). Preoperative values for heart rate and blood pressure were similar in both groups. During induction the lowest heart rate and systolic blood pressure were determined. As baseline heart rate and blood pressure vary with age, the change in these parameters was expressed as a percentage change from the baseline value for each child ( Table 7) . Patients receiving halothane recorded a decrease in heart rate (-17.3 ±10.8%), while in patients receiving sevoflurane heart rate was maintained or slightly increased (1.9±17%). The reduction in systolic blood pressure during induction was more marked in patients receiving halothane (26.9±10.9% versus 14.3±19.2%). In the halothane group, four patients developed arrhythmias. One patient required intravenous atropine for bradycardia and associated hypotension, and one patient developed a nodal rhythm without hypotension which spontaneously reverted to sinus rhythm after two minutes. Two patients had episodes of bigeminy which was managed with intravenous atropine in one and lightening of anaesthesia and assisted ventilation in the other. An intraoperative increase in heart rate and blood pressure in a patient receiving sevoflurane was presumed to be due to an inadequate local anaesthetic block, and settled following intravenous fentanyl.
All recovery room parameters demonstrated significantly more rapid emergence from anaesthesia in patients who received sevoflurane ( Table 4 ). The time to achieve a modified Aldrete Score (see Appendix 1) of 8 or higher was also significantly shorter in patients receiving sevoflurane.
Objective pain/discomfort scores (see Appendix 2 ) were greater in patients who received sevoflurane when tested at 0, 10, 20, 30, and 40 minutes after arrival in the recovery room ( Figure 2 ). All patients received paracetamol. Six patients received oral paracetamol (20 mg/kg) with the premedication prior to surgery and the remaining patients received rectal paracetamol (25 to 30 mg/kg) following the induction of anaesthesia. Seven patients required additional analgesic agents in the recovery room (three in the halothane group and four in the sevoflurane group). Intravenous morphine or fentanyl was required in four patients, and oral codeine in three patients. Six of these patients had inguinal incisions (orchidopexy, hernia repair, or division of varicocoele), and one had an inadequate caudal anaesthetic block following a circumcision.
The incidence of recovery events are listed in Table  8 , and were graded by the nurse observer as mild or moderate. A higher incidence of excitement was noted in the patients who received sevoflurane. Overall recovery success, defined as the absence of any of the adverse recovery events, was greater in the halothane group (Table 9) .
No significant changes were seen between laboratory haematology and chemistry tests before the study and two hours following cessation of anaesthesia. Minor increases in lactate dehydrogenase were noted in two patients and considered to reflect haemolysis of the sample as it was withdrawn from the intravenous cannula postoperatively. Following a cystoscopy one patient was noted to have protein and blood in the postoperative urinalysis and this was presumed to be due to surgical instrumentation. Following discharge, five patients (20.8%) in the sevoflurane group and eight patients (30.7%) in the halothane group experienced nausea and/or vomiting. Ongoing drowsiness was noted in two patients from the sevoflurane group and three patients from the halothane group. These differences were not statistically significant. None of the patients had any recall of intraoperative events. In answer to the question "Would you like your child to have the same anaesthetic administered in the future?", forty-three replied "yes" and seven "maybe" (three from the sevoflurane group and four from the halothane group).
DISCUSSION
The results of this study indicate that sevoflurane is a satisfactory alternative to halothane for paediatric day case surgery. The low pungency of sevoflurane allows its use as an inhalational induction agent. Sevoflurane has an improved cardiovascular profile compared with halothane as evidenced by lesser reductions in heart rate and blood pressure during induction and fewer arrhythmias. Emergence from sevoflurane anaesthesia is more rapid, but may be associated with increased excitement or agitation in the recovery room.
The blood:gas partition coefficient of sevoflurane is much lower than that of halothane (0.6 versus 2.3) 5 . However, the rate of inhalational induction depends not only on the solubility of the agent, but also the rate of increase in inspired concentration, the maximum concentration achieved and the degree of airway irritation. Although a tendency to more rapid induction was seen in the sevoflurane group, this did not reach statistical significance. The slow rate of increase in inhalational agent would reduce the difference due to the low solubility of sevoflurane, and the maximum concentrations may not have been MAC equivalents, as nitrous oxide reduces MAC to a lesser degree with sevoflurane compared to halothane 1 . Breath-holding and coughing, which would slow induction, were less common in our patients receiving sevoflurane. As sevoflurane is non-pungent, high initial concentrations are well tolerated and result in significantly more rapid induction 6 . Excitement may also slow induction. In our study, 13 of 24 children receiving sevoflurane and 10 of 26 children receiving halothane were described as displaying excitement during induction. This rate is much higher than a previous study which recorded excitement in 5% of paediatric patients receiving either halothane or sevoflurane in nitrous oxide 5 , and may reflect the slow induction used in our study. Differences may also be due to variation in the subjective classification and grading of excitement by investigators in different institutions. We defined mild excitement as nonpurposeful movement, moderate excitement as movement requiring restraint, and severe if we were unable to maintain a seal with the mask on the child's face. Others have defined excitement as nonpurposeful movement requiring restraint with no grading 1 . Movement or excitement during induction may be of little significance as it tends to be transient, disappears as anaesthesia deepens, and is less frequent with the current practice of more rapid high concentration inductions.
Induction of anaesthesia with sevoflurane was associated with less haemodynamic change. Heart rate was maintained and the reduction in systolic blood pressure was less during induction with sevoflurane compared to halothane. Arrhythmias were also more common in patients receiving halothane. Similar results have been shown in other studies 1, 5, [8] [9] [10] .
The use of sevoflurane for induction and maintenance of anaesthesia was associated with significantly more rapid emergence from anaesthesia as assessed by emergence times and the modified Aldrete recovery score. The Aldrete recovery score aims to provide objective information on the condition of patients in the recovery room, and Aldrete scores of 8 or greater equate with adequate re-647 SEVOFLURANE VS HALOTHANE Anaesthesia and Intensive Care, Vol. 25, No. 6, December 1997 11 . The actual emergence times in this study are relatively long (20 to 30 minutes) due to the study design, which required continuation of anaesthetic agent until the cessation of surgery in an effort to standardize emergence data. This may have contributed to the large difference in times seen between patient groups, as in clinical practice the concentration of volatile agent would be tapered towards the end of the procedure. Premedication, used in all patients to standardize conditions and to improve compliance with gaining baseline monitoring data, may also have contributed to the long emergence times. Discharge times were not significantly affected by more rapid emergence as the logistics of hospitalization such as awaiting surgical review also affect discharge following day case procedures. The potential advantage of rapid emergence in children may be to improve patient safety in the recovery room, rather than achieve earlier discharge from hospital. Although it has been suggested that the incidence of airway complications such as laryngospasm, or apnoeic spells in infants, may be reduced with rapid emergence from a low solubility anaesthetic agent, this has yet to be been confirmed.
The incidence of recovery room excitement and distress was higher in patients who received sevoflurane and emerged more rapidly from anaesthesia. This has been noted in previous studies, and postulated as being due to either inadequate analgesia or an intrinsic central nervous system effect of sevoflurane. Postoperative "restlessness and agitation" have been reduced with use of improved analgesic regimens in some studies 2, 9 , and there is little current evidence for a specific increased cell membrane excitability with sevoflurane 3 . Distress in children emerging from anaesthesia may relate to many factors, including distress at induction, residual effects of anaesthesia and confusion, pain, parental separation, and hunger or thirst. It may be difficult to differentiate pain from other causes of distress: even use of the objective pain/discomfort scale is limited as parameters of crying, moving and agitation are nonspecific.
There were no significant differences in the analgesia provided for both groups. Although correct placement of regional local anaesthetic blocks can not be confirmed in anaesthetized patients, this problem would not be expected to be different in either group. In our study the objective pain-discomfort scores were higher in the sevoflurane group for the first 40 minutes after arrival in the recovery room, and after that time there was little difference in the scores between the two groups ( Figure 2 ). This may in part relate to delayed absorption of paracetamol as the majority of patients received rectal paracetamol 25 to 30 mg/kg following induction of anaesthesia. It is unlikely that sufficient analgesic levels of paracetamol were achieved in the early recovery phase following these short surgical procedures, as peak concentrations are not achieved until 137 minutes following insertion of gelatin suppositories 12 .
The incidence of nausea and vomiting was slightly less in patients following sevoflurane. The overall rate of postoperative vomiting in the first 24 hours following surgery was 20% (6 of 25 in the halothane group and 4 of 24 in the sevoflurane group). This is in accordance with a previous survey of the incidence of postoperative vomiting following paediatric day case procedures (orchidopexy 27%, circumcision 17%, herniotomy 15%) at our hospital 13 . Although reduced vomiting following sevoflurane has also been noted by other groups 2,8 , insufficient patient numbers have been studied with adequate control of the many factors influencing postoperative nausea and vomiting (particularly age, type of premedication and surgical procedure) to confirm a difference in incidence following sevoflurane or halothane.
No significant differences were found when comparing baseline blood tests to those taken following the procedure. Samples were taken at two hours to avoid further venipuncture as this was one of the major concerns of parents enrolling their child in the study, and also to avoid delays in discharge. It is unlikely that changes in renal function would have been detected at this time. Following sevoflurane anaesthesia in children (average 2-3 MAC-hours) peak fluoride levels up to 20 microM have been measured within one hour of completion of anaesthesia, but concentrations rapidly reduce over the subsequent 24 hours without measured changes in renal function 1, 5, 14 . In paediatric practice, the use of T piece systems avoids any potential concerns regarding the degradation of sevoflurane in carbon dioxide absorbents. However, with the increased cost of anaesthetic gases and volatile agents, concerns regarding pollution, and improved paediatric ventilators, the use of circle absorption systems and low flow anaesthesia is increasing. Compound A levels were measured in paediatric patients aged three months to seven years following 5.6±3.5 MAC-hours (mean±SD) of sevoflurane anaesthesia delivered via a circle system with soda lime absorbent and a fresh gas flow of 2 litres/min. Compound A concentrations were 5.4±4.4 ppm (mean±SD), and the maximum concentration recorded in any patient circuit was 15 ppm 15 which is well below the 50 ppm associated with mild renal abnormalities in rat studies. No changes in renal and hepatic function were detected by clinical laboratory tests (urea, creatinine, bilirubin, AST, ALT, alkaline phosphatase, serum osmolality) measured before and 24 hours after anaesthesia 15 .
Sevoflurane is a satisfactory alternative to halothane for inhalational induction in paediatric anaesthesia, and has the advantage of an improved cardiovascular profile. Emergence from anaesthesia is more rapid following sevoflurane, and may improve patient safety in the immediate postoperative period. Adequate analgesia is necessary to minimize pain during the emergence phase.
